File size: 9,472 Bytes
802d85c
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
974cfce
802d85c
4c725af
 
974cfce
802d85c
e2c7df7
 
802d85c
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4c725af
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
802d85c
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
f1159ac
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
---
license: apache-2.0
language:
  - en
library_name: transformers
pipeline_tag: text-generation
tags:
  - moe
  - mixture-of-experts
  - gravity
  - txgravity
  - therapeutics
  - tdc
  - trillion-labs
base_model:
  - trillionlabs/Gravity-30B-A5B
---

# TxGravity-30B-A6B-Open

## Model Summary

**TxGravity-30B-A6B-Open** is a therapeutics-focused, task-specialized model built on the **Gravity-30B-A5B** base. It predicts a broad range of therapeutic properties β€” small-molecule ADMET, toxicity, drug–target interaction, protein–protein and peptide–MHC interaction, and more β€” by converting the **Therapeutic Data Commons (TDC)** benchmark tasks into an instruction format for LLMs, in the same spirit as Google's TxGemma.

TxGravity is **co-developed by SK Biopharmaceuticals (SKBP) and Trillion Labs**.

It is trained on TDC tasks reformatted as single-turn instructions (instruction β†’ answer), covering 57 tasks. Answers are formatted as `(A)`/`(B)` for binary classification or a normalized `000`–`1000` bin for regression.

This release is the open-license version, with any datasets restricted to non-commercial use excluded from training.

| Property | Value |
|---|---|
| Total Parameters | 29.56B |
| Active Parameters | ~6B |
| Architecture | GravityMoE (DeepSeek-V3-compatible) |
| Layers | 52 |
| Routed / Shared Experts | 64 (top-8) / 1 |
| Context Length | 8,192 tokens |
| Precision | bf16 |
| Base model | Gravity-30B-A5B |

> ⚠️ This is a task-specialized property predictor, not a general instruction-tuned or safety-aligned assistant. Its outputs are intended for the TDC-style therapeutic prediction prompts it was trained on. Predictions may be inaccurate, biased, or incomplete and must be independently verified before any experimental, clinical, or decision-making use.

## Performance

Evaluated on the TDC therapeutic benchmark against a reproduced **TxGemma-27B** baseline. Over 60 comparable tasks: **16 wins / 26 ties / 18 losses** (6 tasks excluded for lack of a paper-reported comparison). A win/loss requires the margin to exceed the tie threshold; otherwise the task is scored a tie.

**Wins (16 tasks)** β€” TxGravity beats TxGemma-27B on: `bindingdb_ki`, `bindingdb_ic50`, `protein_sabdab`, `ppbr_az`, `caco2_wang`, `lipophilicity_astrazeneca`, `half_life_obach`, `clearance_hepatocyte_az`, `ld50_zhu`, `bioavailability_ma`, `buchwald_hartwig`, `drugcomb_css`, `drugcomb_loewe`, `drugcomb_zip`, `drugcomb_hsa`, `drugcomb_bliss` β€” spanning binding affinity, ADMET, toxicity, and drug-combination synergy.

Highlights: `bindingdb_ki` PCC **0.750** vs -0.112, `bindingdb_ic50` Spearman **0.766** vs 0.643, `protein_sabdab` MAE **0.969** vs 2.332, `ld50_zhu` MAE **0.651** vs 0.776.

### Full results

Margin is TxGravity - TxGemma, in percentage points (%p) for score metrics or relative percent (%rel) for error metrics (MAE/MSE, lower is better). Up-arrow = higher is better, down-arrow = lower is better.

| Task | Metric | N | TxGravity | TxGemma-27B | Margin | Verdict |
|---|---|---|---|---|---|---|
| bindingdb_ic50 | Spearman ↑ | 35725 | **0.7660** | 0.6430 | +12.3%p | WIN |
| bindingdb_ki | PCC ↑ | 11857 | **0.7500** | -0.1120 | +86.2%p | WIN |
| bioavailability_ma | AUROC ↑ | 128 | **0.7490** | 0.6970 | +5.2%p | WIN |
| buchwald_hartwig | PCC ↑ | 791 | **0.8920** | 0.8550 | +3.7%p | WIN |
| caco2_wang | MAE ↓ | 182 | **0.4160** | 0.4660 | +10.7%rel | WIN |
| clearance_hepatocyte_az | Spearman ↑ | 243 | **0.3240** | 0.2910 | +3.3%p | WIN |
| drugcomb_bliss | MAE ↓ | 59708 | **3.7370** | 3.9280 | +4.9%rel | WIN |
| drugcomb_css | MAE ↓ | 59708 | **7.8380** | 9.4180 | +16.8%rel | WIN |
| drugcomb_hsa | MAE ↓ | 59708 | **3.5840** | 3.7880 | +5.4%rel | WIN |
| drugcomb_loewe | MAE ↓ | 59708 | **6.4130** | 7.6720 | +16.4%rel | WIN |
| drugcomb_zip | MAE ↓ | 59708 | **3.0610** | 3.4100 | +10.2%rel | WIN |
| half_life_obach | Spearman ↑ | 135 | **0.3600** | 0.2890 | +7.1%p | WIN |
| ld50_zhu | MAE ↓ | 1478 | **0.6510** | 0.7760 | +16.1%rel | WIN |
| lipophilicity_astrazeneca | MAE ↓ | 840 | **0.5700** | 0.5950 | +4.2%rel | WIN |
| ppbr_az | MAE ↓ | 559 | **8.2900** | 9.4180 | +12.0%rel | WIN |
| protein_sabdab | MAE ↓ | 99 | **0.9690** | 2.3320 | +58.4%rel | WIN |
| ames | AUROC ↑ | 1457 | **0.8410** | 0.8300 | +1.1%p | TIE |
| bbb_martins | AUROC ↑ | 406 | **0.9190** | 0.8970 | +2.2%p | TIE |
| bindingdb_patent | PCC ↑ | 49028 | **0.5410** | 0.5140 | +2.7%p | TIE |
| carcinogens_lagunin | Accuracy ↑ | 56 | **0.8750** | 0.8930 | -1.8%p | TIE |
| clearance_microsome_az | Spearman ↑ | 221 | **0.5000** | 0.4870 | +1.3%p | TIE |
| clintox | AUROC ↑ | 297 | **0.7610** | 0.7560 | +0.5%p | TIE |
| cyp1a2_veith | AUPRC ↑ | 2517 | **0.9310** | 0.9350 | -0.4%p | TIE |
| cyp2c19_veith | AUROC ↑ | 2534 | **0.8940** | 0.8910 | +0.3%p | TIE |
| cyp2c9_veith | AUPRC ↑ | 2419 | **0.7920** | 0.7820 | +1.0%p | TIE |
| cyp2d6_veith | AUPRC ↑ | 2626 | **0.6840** | 0.6620 | +2.2%p | TIE |
| cyp3a4_veith | AUPRC ↑ | 2467 | **0.8610** | 0.8410 | +2.0%p | TIE |
| dili | AUROC ↑ | 96 | **0.8930** | 0.8890 | +0.4%p | TIE |
| herg | AUROC ↑ | 132 | **0.8930** | 0.9000 | -0.7%p | TIE |
| herg_central | AUROC ↑ | 61379 | **0.8760** | 0.8830 | -0.7%p | TIE |
| herg_karim | Accuracy ↑ | 2690 | **0.7920** | 0.8000 | -0.8%p | TIE |
| hia_hou | AUROC ↑ | 117 | **0.9860** | 0.9860 | +0.0%p | TIE |
| hiv | AUROC ↑ | 8227 | **0.7640** | 0.7930 | -2.9%p | TIE |
| huri | AUPRC ↑ | 4204 | **0.8080** | 0.7920 | +1.6%p | TIE |
| mhc2_iedb_jensen | AUROC ↑ | 26856 | **0.8680** | 0.8500 | +1.8%p | TIE |
| pgp_broccatelli | AUROC ↑ | 245 | **0.9380** | 0.9320 | +0.6%p | TIE |
| sarscov2_3clpro_diamond | AUROC ↑ | 176 | **0.7470** | 0.7250 | +2.2%p | TIE |
| skin_reaction | AUROC ↑ | 82 | **0.6510** | 0.6370 | +1.4%p | TIE |
| tox21 | AUROC ↑ | 15600 | **0.8230** | 0.8430 | -2.0%p | TIE |
| toxcast | AUROC ↑ | 307282 | **0.8970** | 0.9050 | -0.8%p | TIE |
| vdss_lombardo | Spearman ↑ | 226 | **0.5820** | 0.5660 | +1.6%p | TIE |
| weber | AUROC ↑ | 9417 | **0.7180** | 0.7390 | -2.1%p | TIE |
| bindingdb_kd | PCC ↑ | 1630 | **0.5220** | 0.5960 | -7.4%p | LOSS |
| butkiewicz | AUROC ↑ | 401997 | **0.7540** | 0.8620 | -10.8%p | LOSS |
| cyp2c9_substrate_carbonmangels | AUPRC ↑ | 135 | **0.3460** | 0.4730 | -12.7%p | LOSS |
| cyp2d6_substrate_carbonmangels | AUPRC ↑ | 135 | **0.7080** | 0.7380 | -3.0%p | LOSS |
| cyp3a4_substrate_carbonmangels | AUROC ↑ | 135 | **0.6410** | 0.6950 | -5.4%p | LOSS |
| davis | MSE ↓ | 1064 | **0.7600** | 0.6430 | -18.2%rel | LOSS |
| disgenet | MAE | 10495 | β€” | β€” | β€” | excluded |
| gdsc1 | PCC | 35462 | β€” | β€” | β€” | excluded |
| gdsc2 | PCC | 18541 | β€” | β€” | β€” | excluded |
| kiba | MSE ↓ | 4537 | **0.6370** | 0.4600 | -38.5%rel | LOSS |
| leenay | Spearman ↑ | 1520 | **0.1510** | 0.2260 | -7.5%p | LOSS |
| mhc1_iedb_imgt_nielsen | AUROC ↑ | 37197 | **0.9200** | 0.9680 | -4.8%p | LOSS |
| mirtarbase | Accuracy ↑ | 160033 | **0.5550** | 0.8040 | -24.9%p | LOSS |
| oncopolypharmacology | PCC ↑ | 4647 | **0.5050** | 0.5690 | -6.4%p | LOSS |
| pampa_ncats | AUROC ↑ | 408 | **0.6630** | 0.7080 | -4.5%p | LOSS |
| phase1 | AUROC | 561 | β€” | β€” | β€” | excluded |
| phase2 | AUROC | 1279 | β€” | β€” | β€” | excluded |
| phase3 | AUROC | 1200 | β€” | β€” | β€” | excluded |
| sabdab_chen | AUPRC ↑ | 482 | **0.6580** | 0.7080 | -5.0%p | LOSS |
| sarscov2_vitro_touret | AUROC ↑ | 298 | **0.4580** | 0.5300 | -7.2%p | LOSS |
| solubility_aqsoldb | MAE ↓ | 1997 | **0.8550** | 0.8050 | -6.2%rel | LOSS |
| tap | MAE ↓ | 240 | **5.4400** | 4.7850 | -13.7%rel | LOSS |
| uspto | Accuracy ↑ | 221648 | **0.0000** | 0.0880 | -8.8%p | LOSS |
| uspto_yields | PCC ↑ | 170728 | **-0.0571** | 0.1860 | -24.3%p | LOSS |

Also included in this repo as [`summary.csv`](./summary.csv).

## Usage

```python
from transformers import AutoModelForCausalLM, AutoTokenizer
tok = AutoTokenizer.from_pretrained("trillionlabs/TxGravity-30B-A6B-Open")
model = AutoModelForCausalLM.from_pretrained(
    "trillionlabs/TxGravity-30B-A6B-Open", dtype="bfloat16", device_map="auto")

messages = [{"role": "user", "content": "<TDC-formatted instruction here>"}]
ids = tok.apply_chat_template(messages, add_generation_prompt=True, return_tensors="pt").to(model.device)
out = model.generate(ids, max_new_tokens=16)
print(tok.decode(out[0][ids.shape[1]:], skip_special_tokens=True))
```

The model expects TDC-style prompts and answers in TDC format: `(A)`/`(B)` for classification, or a `000`–`1000` normalized bin for regression.

## License
Apache 2.0

## Citation

```bibtex
@misc{txgravity2026,
  title        = {TxGravity-30B-A6B-Open},
  author       = {SK Biopharmaceuticals and Trillion Labs},
  year         = {2026},
  howpublished = {\url{https://huggingface.co/trillionlabs/TxGravity-30B-A6B-Open}}
}
```

This model builds on the Therapeutic Data Commons (TDC) benchmark:

```bibtex
@article{huang2021therapeutics,
  title   = {Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Development},
  author  = {Huang, Kexin and Fu, Tianfan and Gao, Wenhao and Zhao, Yue and Roohani, Yusuf and Leskovec, Jure and Coley, Connor W and Xiao, Cao and Sun, Jimeng and Zitnik, Marinka},
  journal = {Proceedings of Neural Information Processing Systems, NeurIPS Datasets and Benchmarks},
  year    = {2021}
}
```